Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Colchicine

Research Leaders

6 sponsors active, led by Linkoeping University

Related Conditions

Often studied with 11 related conditions

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 5/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 4 (1)

Trial Status

Completed2
Enrolling By Invitation1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT07312136Enrolling By Invitation

MASLD in Type 2 Diabetes in Primary Care - a Follow-up Study

NCT05097963Not ApplicableCompleted

A Study to Evaluate Liver Stiffness With Shear Wave Elastography

NCT00179413Phase 4Completed

Study of Long-term Peg Intron vs. Colchicine in Non-responders.

Showing all 3 trials

Research Network

Common Treatments

  • Colchicine1
  • Endoscopic Ultrasound Shear Wave Elastography1
  • Peg Intron1

Active Sponsors

  • Linkoeping University1
  • Amra Medical AB1
  • Mayo Clinic1
  • Beth Israel Deaconess Medical Center1
  • Schering-Plough1

Top Investigators

Related Conditions

  • Cirrhosis2
  • Advanced Cirrhosis1
  • Sarcopenia1
  • Metabolic Syndrome1
  • Masld Metabolic Dysfunctionassociated Steatotic Liver Disease1

Activity Timeline